At 6.4% CAGR, the Asia Pacific Enteral Nutrition Market is Projected to be Worth US$ 2,942.72 Million by 2030, Says Business Market Insights
According to Business Market Insights research, the Asia Pacific enteral nutrition market was valued at US$ 1,791.10 million in 2022 and is expected to reach US$ 2,942.72 million by 2030, registering a CAGR of 6.4% from 2022 to 2030. Rising cases of malnutrition and premature births and increasing prevalence of gastrointestinal diseases are among the critical factors attributed to the Asia Pacific enteral nutrition market expansion.
Undernourished, overweight or obese, vitamin or mineral deficiency, and poor diet-related noncommunicable diseases are all categorized under malnutrition. As per World Health Organization (WHO) data, ~1.9 billion adults were overweight or obese, whereas 462 million were underweight in 2021. Additionally, 39 million children under the age of 5 were overweight, 149 million had slow growth and development owing to the chronic lack of access to nutritious food, and 45 million were wasted (too thin for height). ~45% of deaths among children aged less than 5 are associated with undernutrition. As per the July 2022 data by the United Nations International Children's Emergency Fund (UNICEF), the prevalence of undernourishment reached 9.3% in 2020 from 8.0% in 2019; it further jumped to 9.8% in 2021.
As per WHO data published in 2023, ~13.4 million preterm births (more than 1 in 10 births) were reported worldwide in 2020. Additionally, most preterm births (more than 60%) occurred in southern Asia in 2021, which is becoming a global concern. On average, 12% of births in low-income countries and 9% in high-income countries are premature births. A large number of premature babies suffer from low weight and undeveloped immunity, which puts their lives at risk. Most medical guidelines advise enteral nutrition for supporting the optimal growth of preterm infants if they are unable to drink, suck, swallow, and breathe. Hence, the demand for enteral nutrition is growing with the increasing number of cases of preterm births.
On the contrary, complications associated with enteral feeding systems hampers the growth Asia Pacific enteral nutrition market.
Based on product type, the Asia Pacific enteral nutrition market is bifurcated into general and disease specific. The general segment held 57.1% share of the Asia Pacific enteral nutrition market in 2022, amassing US$ 1,022.43 million. It is projected to garner US$ 1,668.09 million by 2030 to expand at 6.3% CAGR during 2022-2030.
In terms of application, the Asia Pacific enteral nutrition market is segmented into gastrointestinal disorders, metabolic/inborn errors of metabolism, food allergy, renal disease, liver disease, oncology, neurology, and others. The gastrointestinal disorders segment held 30.2% share of the Asia Pacific enteral nutrition market in 2022, amassing US$ 540.50 million. It is projected to garner US$ 882.15 million by 2030 to expand at 6.3% CAGR during 2022-2030.
Based on age group, the Asia Pacific enteral nutrition market is bifurcated into adult and pediatric. The adult segment held 84.6% share of the Asia Pacific enteral nutrition market in 2022, amassing US$ 1,515.04 million. It is projected to garner US$ 2,461.08 million by 2030 to expand at 6.3% CAGR during 2022-2030.
By distribution channel, the Asia Pacific enteral nutrition market is segmented into hospital pharmacies, retail stores, e-commerce, and others. The hospital pharmacies segment held 57.5% share of Asia Pacific enteral nutrition market in 2022, amassing US$ 1,029.83 million. It is projected to garner US$ 1,663.44 million by 2030 to expand at 6.2% CAGR during 2022-2030.
Based on country, the Asia Pacific enteral nutrition market is categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China held 27.4% share of Asia Pacific enteral nutrition market in 2022, amassing US$ 490.37 million. It is projected to garner US$ 831.95 million by 2030 to expand at 6.8% CAGR during 2022-2030.
Key players operating in the Asia Pacific enteral nutrition market are Abbott Laboratories, Nestle SA, Danone SA, Fresenius SE & Co KGaA, B Braun SE, Reckitt Benckiser Group Plc, Royal FrieslandCampina NV, Arla Foods amba, Perrigo Co Plc, and Fonterra Co-Operative Group Ltd, among others.
In Nov 2021, Fonterra and VitaKey Inc. announced a transformative dairy science collaboration to further unlock the benefits of Fonterra's probiotic strains. VitaKey specializes in precision delivery of nutrition - an emerging area of research that seeks to deliver the right nutrients, in the right amount, to the right part of the body at the right time.
In July 2023, Fonterra announced a new corporate ventures arm to incubate, scale and invest in ventures in the area of nutrition science.
Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com
